Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $1,749,796.30 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 3,031 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $577.30, for a total transaction of $1,749,796.30. Following the completion of the sale, the executive vice president now owns 353 shares of the company’s stock, valued at $203,786.90. This trade represents a 89.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Thursday, February 27th, Myriam Curet sold 2,401 shares of Intuitive Surgical stock. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00.
• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The shares were sold at an average price of $589.75, for a total value of $240,618.00.

Intuitive Surgical Stock Down 1.1 %

Shares of ISRG stock opened at $566.98 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s fifty day simple moving average is $570.66 and its 200 day simple moving average is $530.08. The firm has a market capitalization of $201.95 billion, a P/E ratio of 88.45, a P/E/G ratio of 5.85 and a beta of 1.39.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Evercore ISI upped their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in ISRG. Bennett Selby Investments LP grew its holdings in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC raised its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after acquiring an additional 18 shares during the last quarter. AlphaCore Capital LLC lifted its holdings in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock worth $235,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC grew its stake in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Finally, Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.